Tenstorrent’s Open Chiplet Atlas ecosystem introduces open, royalty-free specifications intended to support multivendor ...
Omeros Corporation (Nasdaq: OMER) today announced the closing of the asset sale and licensing transaction between Omeros and Novo Nordisk for the candidate drug zaltenibart (formerly OMS906).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback